{"id":309,"date":"2016-11-04T01:09:47","date_gmt":"2016-11-04T01:09:47","guid":{"rendered":"http:\/\/pulmonologi.fk.uns.ac.id\/?page_id=309"},"modified":"2021-03-03T04:21:31","modified_gmt":"2021-03-03T04:21:31","slug":"","status":"publish","type":"page","link":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/penelitian\/multicenter\/","title":{"rendered":"","raw":""},"content":{"rendered":"","protected":false,"raw":""},"excerpt":{"rendered":"","protected":false,"raw":""},"author":1,"featured_media":0,"parent":1727,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_en_post_content":"","_en_post_name":"","_en_post_excerpt":"","_en_post_title":"","_id_post_content":"<ul>\n \t<li>2012, A Clinical Outcomes study to compare the effect of Fluticasone Furoate\/Vilanterol Inhalation Powder 100\/25mcg with placebo on Survival in subjects with moderate Chronic Obstructive Pulmonary Disease(COPD) and a history of or at Increased risk for cardiovascular Disease. PARELEX Number 110812, 090828 (SUMMIT STUDY)<\/li>\n \t<li>2012, Protocol SAS115399 : A Safety and Efficacy Study of Inhaled Fluticasone Propionate\/Salmeterol Combination versus Inhaled Fluticasone Propionat In the treatment of Adolescent and Adult Subjects wih Asthma (ASMALABA)<\/li>\n \t<li>2012, Outgoing A Prospective, Randomized, Multicenter, Open Label Phase III Study of Active Specific Immunotherapy with Racotumomab Plus Best Support Treatment in Patients with Advanced nonsquamous Non-Small Cell Lung Center<\/li>\n \t<li>2011, A randomized, parallel-group, open-label, multicentre, 3-month phase IV, efficacy and tolerability study of budesonide\/folmoterol(Symbicort\u00ae Turbuhaler\u00ae160\/4.5\u03bcg\/inhalation, 2 inhalation twice daily) added to tiotropium(Spiriva\u212218\u03bcg\/inhalation, 1 inhalation once daily)compared with tiotropium (Spiriva\u00ae18\u03bcg\/inhalation, 1 inhalation once daily) alone in severe chronic obstructive pulmonary disease (COPD) patients. (SECURE I)<\/li>\n \t<li>2008, Cross sectional study of prevalence and distribution of cigarette smoking habits in Indonesian male hospital patients with non-tobacco-related admissions diagnoses<\/li>\n \t<li>2006, An open label, randomized, parallel group, multicentre, phase III study to assess efficacy, safety and tolerability of gefitinib (IRESSATM) (250 mg tablet) versus carboplatin\/paclittaxel doublet chemotheraphy as first-line treatment in selected patients with advanced (stage IIIB or IV) non \u2013 small cell lung cancer (NSCLC) in Asia (IPASS)<\/li>\n \t<li>2004, Efficacy and safety of Symbicort \u201cTurbuhaler\u201d 160\/4.5 \u03bcg\/Inhalation, two inhalations twice daily plus as-needed compared with seretideTM DIiskus TM 50\/500 \u03bcg\/inhalation, one inhalation twice daily plus terbutalin Turbuhaler 0,4 mg\/inhalation as-needded-a 6-month, randomised,double-blind, parallel-group, active controlled, multinational phase IIIB study in adult and adolescent patients with persistent asthma (AHEAD)<\/li>\n<\/ul>","_id_post_name":"multicenter","_id_post_excerpt":"","_id_post_title":"Multicenter","edit_language":"en","site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_joinchat":[],"footnotes":""},"class_list":["post-309","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/comments?post=309"}],"version-history":[{"count":2,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/309\/revisions"}],"predecessor-version":[{"id":362,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/309\/revisions\/362"}],"up":[{"embeddable":true,"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/pages\/1727"}],"wp:attachment":[{"href":"https:\/\/pulmonologi.fk.uns.ac.id\/en\/wp-json\/wp\/v2\/media?parent=309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}